Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...

In the past 50 years or so, we have come face to face with unusual climatic occurrences, weather changes and environmental disasters. These are a corollary of the global pursuit of rapid growth, in particular rapid growth of industrialisation, and very often the mindless and predatory exploitation of natural resources. These have happened across the world, without distinguishing between rich and poor nations... In the increasingly integrated world that we live...

Developing countries will now have to battle IP issues related to new agricultural technologies at WIPO instead of WTO The World Intellectual Property Organization has announced clearly that it intends to play a role—and considering the clout WIPO enjoys it implies a significant part—in promoting intellectual property (IP) in agriculture to enhance productivity. The UN body stepped into this touchy arena with a seminar at its Geneva headquarters that has gone...

India’s FTAs pip generic drugs production Lot More For Less     * Generic drugs from India play a major role as antiretroviral drugs across the developing world     * A 2010 study says 80% of the medicines used by donor-funded programmes to treat people with HIV were sourced from India     * It’s cut down treatment costs drastically, from $10,000 to $80     * Stronger IP regimes may hamper production of generics *** The right of...

Moves by developed nations such as the United States to tighten intellectual property laws are threatening to limit production and distribution of generic drugs, which experts say have been and will remain key in the prevention and treatment of HIV/AIDS and currently account for 80 percent of HIV/AIDS treatment. These efforts are taking shape in two spheres. The first is in discussions on the outcome document that member states are expected...